Yang Bo, Huo Awei, Li Ling, Qiu Huaiming
Department of Radiology, General Hospital of Central Theater Command of the People's Liberation Army, PLA, Wuhan, China.
Turk Gogus Kalp Damar Cerrahisi Derg. 2025 Jul 21;33(3):357-364. doi: 10.5606/tgkdc.dergisi.2025.27140. eCollection 2025 Jul.
The aim of this study is to identify risk factors for recurrence of hemoptysis after bronchial artery embolization and to evaluate patient feedbacks on this intervention.
Between August 2013 and October 2022, a total of 122 patients (83 males, 39 females; mean age: 59.7±17.3 years; range, 13 to 91 years) who underwent bronchial artery embolization were retrospectively analyzed. The endpoint event was hemoptysis recurrence or death. Baseline data of the patients, technical and clinical success rates, complications, postoperative recovery time in hospital and patient satisfaction and re-acceptance rates were evaluated via a questionnaire.
During follow-up, 24 patients died. A total of 50 patients experienced recurrence, and the overall recurrence rate was 40.98%. Patients with embolization of single culprit artery had a higher recurrence-free survival rate (p=0.049). Of 97 respondents, 81 were satisfied with the result of the procedure and 84 gave consent for re-intervention, if necessary.
Bronchial artery embolization is a safe and effective method of hemoptysis suppression, particularly for those with embolization of single culprit artery. Better suppression of hemoptysis and strengthening communication with patients in the perioperative period can improve the patient satisfaction.
本研究旨在确定支气管动脉栓塞术后咯血复发的危险因素，并评估患者对该干预措施的反馈。
回顾性分析2013年8月至2022年10月期间共122例行支气管动脉栓塞术的患者（男性83例，女性39例；平均年龄：59.7±17.3岁；范围13至91岁）。终点事件为咯血复发或死亡。通过问卷调查评估患者的基线数据、技术成功率和临床成功率、并发症、术后住院恢复时间以及患者满意度和再次接受率。
随访期间，24例患者死亡。共有50例患者出现复发，总体复发率为40.98%。栓塞单一责任动脉的患者无复发生存率较高（p=0.049）。在97名受访者中，81人对手术结果满意，84人同意在必要时再次接受干预。
支气管动脉栓塞术是一种安全有效的控制咯血的方法，尤其适用于栓塞单一责任动脉的患者。更好地控制咯血并在围手术期加强与患者的沟通可以提高患者满意度。
